Bowel Function After Minimally Invasive Urogynecologic Surgery

Bowel Function After Minimally Invasive Urogynecologic Surgery: A Prospective Randomized Controlled Trial

The purpose of this study is to assess the effect of a standardized postoperative bowel regimen of over-the-counter medications in subjects undergoing minimally invasive urogynecologic surgery.

See above

Inclusion Criteria:

• Planning to be admitted to the hospital to undergo minimally-invasive urogynecologic surgery at Strong Memorial Hospital.

Procedures may include:

• robot-assisted laparoscopic sacrocolpopexy
• sacrospinous ligament suspension
• uterosacral ligament suspension/paravaginal defect repair
• colpocleisis
• cystocele repair

Additional procedures may include:

• hysterectomy
• adnexectomy
• culdoplasty
• minimally invasive sling procedure (TVT or TOT)
• periurethral collagen injections
• enterocele repair

Exclusion Criteria:

• Planning to undergo laparotomy.
• Undergoing rectocele or perineocele repair as part of surgery.
• Taking Miralax, laxatives, enemas, or suppositories daily, at the time of enrollment.
• Presence of a colostomy.
• Chronic kidney disease
• Insulin-dependent diabetes mellitus
• Known cardiac disease
• Gastric ulcers
• Difficulty swallowing or esophageal stricture
• Persistent nausea and vomiting
• Signs and symptoms consistent with bowel obstruction